As detailed in the Appreciation piece written by Carol Moberg, Ralph's discovery and investigation of DCs constituted an enormous contribution to immunology. However, Ralph's influence extended far beyond the strictly scientific. Below, some of Ralph's closest colleagues and friends reflect on the long-lasting effects of his unwavering mentorship, enthusiasm, generosity, and friendship.
Also in this issue is a Perspective, originally commissioned by Ralph and written by Robin Weiss and Peter Vogt. Ralph passed away before he could read this engaging piece, which celebrates the centennial of the publication in the JEM of the Nobel Prize-winning work of Peyton Rous. In addition to their Nobel Prizes, Ralph and Peyton Rous shared the distinctions of being longtime leaders of Rockefeller laboratories and editors of this journal.
Michel Nussenzweig
When Zanvil Cohn introduced me to Ralph Steinman in 1977, he was working at the bench. Ralph continued to work during our 45 minute interview, at the end of which he told me that my ideas were from "outer space," and that I should drop them and come work with him on DCs. The next day I did, and it was one of the best decisions I ever made.
Those three years working together were among the most exciting in my ca reer in science. We worked in a small room with Ralph's technician, Maggi Pack. Our routine was to spend the entire morning collecting and processing spleens, and talking about the experiments. There were always so many different possibilities for experiments, but never enough DCs. Despite the daily frustrations of difficult technical work at the bench, I was thrilled to be there and to spend the day talking to Ralph. He taught me how to do experi ments, how to think about science, and how to be a mentor. Later, he also taught me how to be an editor of the JEM.
Others will comment on Ralph's tremendous determina tion, intelligence, and generos ity. For me Ralph was above all a great friend and mentor. He will be sorely missed. Ralph was unique in his ability to have a broad perspective for what was scientifically and potentially clinically important, yet maintain a profound un derstanding of the cellular and molecu lar basis for the underlying biology. Ralph used this broad, yet specific, ex pertise and committed himself to trans lational research in two major ways. First, as an editor of the JEM, he was instrumental in strongly encouraging submission of papers describing experi ments with human tissues, allowing those doing this type of research to publish it in a high quality journal an Assistant Professor in the same de partment in which I had trained, I knew I needed to establish my inde pendence. It was hard to work down the hall from Ralph and not get caught up in DC mania. DCs were finally be ing accepted by the immunology com munity. However, I was determined to keep focused on my own research program. This worked well, or so I thought, for a decade. At that time Gwen Randolph and I were studying a funny subset of monocytes that, after trans migrating endothelium would cross back from the basal to the apical side. We discussed these data with Ralph. He suggested a few experiments. Sure enough, these cells turned out to be monocytes that differentiated into im mature DCs and were crossing the en dothelium from the abluminal to the luminal side, the way they would enter afferent lymphatic channels in vivo.
The lesson I learned from this is that there are two types of immunologists: Those who are studying DCs and those who don't realize they are studying DCs!
Bob Seder
My first interaction with Ralph was in 1988 when I was a second year medical resident at New York Hospital/Cornell Medical Center doing a rotation in his younger scientists, the application of exacting rigor in scientific evaluation, the importance of moving beyond in vitro and animal models into human studies, and the key role in the scien tific community of his beloved jour nal, the JEM. During our 30 years together on the editorial board, I saw no one work harder or do more behind the scenes to sustain the journal's phi losophy and effectiveness than Ralph.
If I had to pick one word to summarize Ralph's personality and impact, it would be "generativity." Generativity describes all three of Ralph's greatest interests: family, ed ucation, and research. It was also his subject matter: DCs generate an immune response by educating other cells in their family. Ralph did what he studied.
Ralph gave a Harvey lecture in Jan uary 2010. In one of those decisions for which I will never forgive myself, I allowed another obligation to keep me from attending. Later, Julien Vau bourgeix, one of my postdoctoral fel lows, told me about the lecture and said, "Now I know why I want to be a scientist!" No tribute could have pleased Ralph more, perhaps not even a Nobel Prize.
Bill Muller
Ralph had an uncanny ability to cut right to the heart of the matter, whether it was designing an experiment, summa rizing a manuscript, critiquing a grant, or describing a movie plot. He could take the most complex data and distill the es sence into one or two concise simple sentences that made one think, "That's so obvious! Why didn't I think of that?" Ralph had the most amazing smile. It was radiant. It was genuine; he looked so relaxed when he was smil ing. And he always seemed to be smil ing, no matter how life was treating him. The smile was infectious and those around him found themselves smiling, too. Just to be around him made me feel better.
When people would ask about my relationship with Ralph, I used to say that I was his first graduate student, and the only one NOT to work on DCs. When I came back to Rockefeller as encouragement of submissions by au thors able to make a convincing ar gument for the significance of their findings. Above all, Ralph was a person able and extremely positive colleague and mentor who encouraged the very best from all of us, but in particular from younger scientists struggling to make their name in the field. Ralph Steinman left us with many professional and life lessons but his last, on how to confront death with enormous courage and dignity, was to the me the most moving and powerful. In the end, the Nobel was merely the final triumph in the life of a man who was already a laureate not only in his outstanding re search accomplishments and dedication to the translation of science for the bet terment of humanity but also for his personal integrity. Thanks, Ralph, for your friendship and support and for leaving us with this inspiring legacy! Anne O'Garra Ralph Steinman was already very famous as the father and discoverer of DCs by the time I met him. He was modest, and always had a persistent excitement with other people's new findings, espe cially those related to DCs. I got to know Ralph, first in the 1990s when we coorganized (together with Jacques Banchereau) the first of a few Dendritic Cell Keystone Conferences, and then through the JEM Board, which I joined in 2004. He was the most effective conference organizer, thoroughly re viewing each abstract, attending every single talk, taking detailed notes, and, importantly, engaging with and en couraging young researchers. He was the most diligent reviewer and editor I have ever met, always concerned about publishing new findings and re acting against overzealous reviewers, who either nitpicked or asked for too much. As he used to say "publishing manuscripts is an evolving process -we cannot have all the answers in the one paper, there will always be some un answered questions, but science must go forward." I learned a lot from Ralph and will miss him sorely, both as a friend and as a mentor.
Ralph was tireless, rigorous, deman ding, courageous, humble, and de termined. I speak for so many of his colleagues in saying that he was also incredibly loyal. He emphasized our strengths and was honest yet respectful and supportive of our weaknesses. Al though the Nobel Prize is certainly the highest scientific honor, and well de served and appreciated, the greatest prize for Ralph and his legacy will be for the scientific community to dedi cate themselves to developing success ful vaccines to prevent HIV, malaria and tuberculosis and help treat cancer. His scholarship, mentorship, and friend ship will be missed in a way that words cannot convey. As such, it is not just DCs that were "special."
Gerold Schuler
Ralph changed my life in many ways. My time with him was just wonderful. The scientific findings we made and the training I received have obviously helped me in my career. However, he also impressed and influenced me very deeply as a caring and understanding human being, especially because his family was so important to him. I con sider myself lucky that Ralph was my teacher, mentor, and friend. I miss him and hope to see him again in other spheres. Ralph, thank you for all you gave me.
Alan Sher
Ralph Steinman leaves a legacy that extends beyond his groundbreaking discovery of DCs and the numerous seminal contributions to immunology of his group at Rockefeller. To the many of us who were fortunate to have interacted closely with Ralph, he served as a model of scientific leader ship to which we all might aspire. His dedication to the field of immunology extended beyond advocating for DCs and vaccines, his own areas of research interest. He was also vocal in his oppo sition to trends in the field that he believed to be misdirected or unfruit ful. As a senior editor of the JEM, he was uncompromisingly rigorous but at the same time notably generous in his read by so many basic immunologists. Second, Ralph devoted much of his own efforts to what he called "Vaccine Science" to develop vaccines for infec tions including HIV, malaria, and tuber culosis, where T cells play a critical role.
Ralph directly trained or played a major role in the development and suc cess of a very large number of accom plished, firstrate investigators around the world. As a board member of Key stone he promoted the idea for the short talks by young investigators at plenary sessions. Over the past few years, he spent a substantial amount of time estab lishing The International Society for Dendritic Cell and Vaccine Science, "a webbased society to promote col laboration of dendritic cell biologists and vaccine scientists." A highlight of Ralph's vision of integrating the biology of DCs and Vaccine Science was DC2010: Forum on Vaccine Science. Antonio Lanzavecchia, Federica Sallusto, Markus Manz, and Giorgio Noseda or ganized this meeting, which took place September 26-30 in Lugano, Switzer land almost exactly one year prior to his passing. It was a wonderful scientific program with outstanding basic and clinical talks on the role of DCs. Ralph was the closing speaker, as was fitting.
Over the past several years, Ralph remained very private and rarely talked about his illness. I would ask periodi cally about how he was doing, purely out of courtesy, and he would then de scribe things in precise detail and some times wonderment about how some of the treatments were going, especially the potency of anti-CTLA4. How ever the majority of our conversations focused on data, his family, and an oblig atory and uninterrupted 10 minutes on the perils of research funding. Having known Ralph for over 20 years, I was fortunate to get to know his wife Claudia and daughter Alexis very well. They are warm, engaging, outgoing, and un derstanding of the constant intrusions by so many of us into Ralph's time. Ralph was always in a good mood when he was with his family, which also includes Adam and Leslie, their re spective spouses, and of course his pre cious grandchildren.
Jacques Banchereau
I met Ralph nearly 20 years ago. At the time, our laboratories had concluded that GMCSF was critical for the gen eration of DCs in vitro, both in mice and humans. This was the beginning of a long friendship and collaboration centered on his original discovery that those DCs were an essential element of the immune system. DC meetings were launched, starting in Annecy, France, in 1994. At last, the scientific community had realized that these "dendritic cells" were not just funny macrophages! Ralph and I did not miss a DC meet ing for the next 16 years.
Ralph was a true friend and the most insightful and generous collaborator, as he never refrained from being sincere. My decision to leave industry (Schering Plough/DNAX) and join the Ameri can academic system to build the Baylor Institute for Immunology Re search in Dallas did not enthuse Ralph, as he was worried about the funding of human studies. Yet, this gave us the opportunity to work together on a program project aimed at using DCs to induce tumorspecific immune re sponses in cancer patients. This project eventually got funded and allowed us to demonstrate the therapeutic value of DCs generated by culturing monocytes with GMCSF and interferon. Even tually Ralph used these very cells for his own therapy! I will never forget those long grant writing days with Ralph, Karolina Palucka, Joseph Fay, and Madhav Dhodapkar. What a privilege to be able to discuss DCs with Ralph and, during the breaks, learn from him how to dance salsa! Though Ralph spent most of his life designing and performing the most ele gant mouse studies, he was the strongest supporter of human immunology and was highly engaged in the field in many ways. After all, with Madhav Dhodapkar and Nina Bhardwaj, he was among the first to inject human DCs into volun teers and to demonstrate their immuno genicity in humans. In recent years, Ralph spent countless hours promoting this field. As an advisor to the Dana Foundation, he established grants to sup port investigators dedicated to human immunology studies. He led the Dana Foundation to establish an Award in Human Immunology Research given in collaboration with the American Associ ation for Immunologists (AAI) every year at the AAI annual meeting. I have been a privileged recipient of this pre cious prize. Ralph also spent consider able time with the National Cancer Institute to encourage the development of cancer immunotherapy with an em phasis on cancer vaccines, of which he was an ardent advocate. He was impa tient to see faster progress and increased funding for this field. As if to compen sate, he slept short nights, ran in the early mornings, and kept an amazing pace during his long working hours. And he never hesitated to take time from his busy schedule to help his friends. He traveled south to Texas countless times to support the Baylor Institute for Im munology Research, as well as the MD Anderson Immunology program in Houston. There, he encouraged us to move forward with our studies on human lupus and cancer and with the development of HIV clinical trials. We owe it to this remarkable scientist and friend to "keep up the good work," as he used to tell us, always with a smile. Ralph's amazing mind has always commanded my greatest admiration and respect. During his extraordinary career, he trained many excellent students and postdocs from many countries, including Asian countries such as China, Korea, and Japan. He was al ways encouraging and enthusiastic and excited about findings, even those of others. Every time we met him, he asked "What's new today?"
Ralph passed away after a four and a half year battle with pancreatic cancer. Ralph was passionately involved in science until the last days of his life. The news of Ralph's passing left me with a profound sense of grief, not only because I believe he himself deeply regretted the "loss" of his own life but also because Ralph's passing will be a great loss to the field of immu nology. I sincerely pray for him to rest in peace.
Fern Cohn
I remember the day very clearly. Zan came home from the laboratory and announced, "Ralph made a very im portant observation today." Then fol lowed the details. Ralph had come to Zan's office to ask him to look into his microscope. Zan went to Ralph's laboratory, looked through Ralph's microscope, and saw what Ralph had just seen.
It was their very first view of what they were later to call the dendritic cell.
